ATE302023T1 - Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen - Google Patents

Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen

Info

Publication number
ATE302023T1
ATE302023T1 AT00980159T AT00980159T ATE302023T1 AT E302023 T1 ATE302023 T1 AT E302023T1 AT 00980159 T AT00980159 T AT 00980159T AT 00980159 T AT00980159 T AT 00980159T AT E302023 T1 ATE302023 T1 AT E302023T1
Authority
AT
Austria
Prior art keywords
nitrogen oxide
airway structure
treat airway
treat
nitrogen
Prior art date
Application number
AT00980159T
Other languages
English (en)
Inventor
Josephine Hjoberg
Goeran Hedenstierna
Marieann Hoegman
Original Assignee
Aga Ab Publ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aga Ab Publ filed Critical Aga Ab Publ
Application granted granted Critical
Publication of ATE302023T1 publication Critical patent/ATE302023T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00980159T 1999-11-03 2000-11-02 Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen ATE302023T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903985A SE9903985D0 (sv) 1999-11-03 1999-11-03 Use of nitric oxide
PCT/SE2000/002153 WO2001032202A1 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction

Publications (1)

Publication Number Publication Date
ATE302023T1 true ATE302023T1 (de) 2005-09-15

Family

ID=20417596

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00980159T ATE302023T1 (de) 1999-11-03 2000-11-02 Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen

Country Status (20)

Country Link
EP (1) EP1225913B8 (de)
JP (1) JP2003513048A (de)
CN (1) CN1230199C (de)
AR (1) AR026335A1 (de)
AT (1) ATE302023T1 (de)
AU (1) AU778347B2 (de)
BR (1) BR0015329A (de)
CA (1) CA2389655A1 (de)
CZ (1) CZ20021559A3 (de)
DE (1) DE60022070T2 (de)
EE (1) EE200200240A (de)
ES (1) ES2248153T3 (de)
HU (1) HUP0203065A3 (de)
IL (1) IL149170A0 (de)
MX (1) MXPA02004069A (de)
NO (1) NO20022113D0 (de)
PL (1) PL354653A1 (de)
SE (1) SE9903985D0 (de)
WO (1) WO2001032202A1 (de)
ZA (1) ZA200203391B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
US6601580B1 (en) * 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
AU2003226603A1 (en) 2002-04-19 2003-11-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
CN1674942A (zh) * 2002-06-21 2005-09-28 联邦高等教育系统匹兹堡大学 氧化氮、血红素加氧酶－1和血红素降解产物的药学用途
WO2010064522A1 (ja) * 2008-12-03 2010-06-10 株式会社Ｌｔｔバイオファーマ 修飾型スーパーオキサイドジスムターゼ含有吸入剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1875917A3 (de) * 1990-12-05 2012-11-28 The General Hospital Corporation Gasmischung zur Behandlung von Lungengefässverengung
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
WO1996039409A1 (en) * 1995-06-05 1996-12-12 Nitromed, Inc. Nitrosylated and nitrated superoxide oxidants and reductants
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds

Also Published As

Publication number Publication date
PL354653A1 (en) 2004-02-09
EE200200240A (et) 2003-06-16
CA2389655A1 (en) 2001-05-10
AU1745601A (en) 2001-05-14
EP1225913A1 (de) 2002-07-31
EP1225913B8 (de) 2005-10-19
HUP0203065A2 (hu) 2003-01-28
BR0015329A (pt) 2002-07-09
ES2248153T3 (es) 2006-03-16
SE9903985D0 (sv) 1999-11-03
DE60022070D1 (de) 2005-09-22
HUP0203065A3 (en) 2006-07-28
EP1225913B1 (de) 2005-08-17
DE60022070T2 (de) 2006-03-30
AR026335A1 (es) 2003-02-05
MXPA02004069A (es) 2003-08-20
IL149170A0 (en) 2002-11-10
AU778347B2 (en) 2004-12-02
CN1387441A (zh) 2002-12-25
NO20022113L (no) 2002-05-02
ZA200203391B (en) 2002-12-20
CN1230199C (zh) 2005-12-07
CZ20021559A3 (cs) 2003-05-14
WO2001032202A1 (en) 2001-05-10
JP2003513048A (ja) 2003-04-08
NO20022113D0 (no) 2002-05-02

Similar Documents

Publication Publication Date Title
ATE288748T1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
ATE371457T1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
DE69830660D1 (de) Behandlung von atemstillstand im schlaf
ATE365042T1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
ATE281167T1 (de) Verwendung von makroliden zur behandlung von trockenen augen
ATE301703T1 (de) Verwendung von zusammensetzungen zur textilpflege
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
ATE526982T1 (de) Verwendung von neublastin-polypeptide zur behandlung von neuropathischen schmerzen
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
ATE339955T1 (de) Verwendung von escitalopram zur behandlung von generalisierten angstzuständen
EP1117431A4 (de) Behandlung von acidose
ATE418552T1 (de) Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE289196T1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
DE60026644D1 (de) Verwendung von Ferulasäure zur Behandlung von Bluthochdruck
ATE302023T1 (de) Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen
DE60110748D1 (de) Behandlung von fluorkohlenstoff-beschickungen
ATE317261T1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
DE60120990D1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE404203T1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
ATE255892T1 (de) Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa
DE69934336D1 (de) Verwendung von halofuginone zur behandlung von urethralstriktur
ATE360418T1 (de) Verwendung von hydroxypyridon-haltigen puderzubereitungen zur behandlung von unterschenkel- und druckgeschwüren
IL138709A0 (en) METHODS FOR PROMOTING THE HEALING OF CUTANEOUS WOUNDS AND ULCERS USING COMPOSITIONS OF α-D-GLUCANS

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties